Active Implants, a Memphis, Tenn., maker of hip, knee and spine implants, has raised $6.7 million of an expected $21 million second round of funding, VentureWire reports (subscription required). The company’s investors are mostly small local firms and Discure, an Israeli company from which Active Implants has licensed technology.
The company is developing implants made of unspecified “pliable” materials that are designed for possible use in patients who, for instance, might not yet qualify for a full hip replacement. In a message from the company president, Active Implants bills its potential products as “an early intervention implant option that is not available today.”
CEO Stephen Bradshaw told VentureWire that the company is preparing for commercialization in Europe sometime in the second half of this year.